NCT06967701

Brief Summary

The challenges of living with type 1 diabetes often stand in the way of getting enough exercise. Continuous blood sugar monitoring has revolutionized type 1 diabetes care but remains underutilized to sustainably support exercise and related behaviors. This remote participation-based research will develop a mobile application that delivers personalized encouragement and data-driven health insights based upon patterns in blood sugar, exercise, mood, and sleep, to assist people with type 1 diabetes in exercising more frequently and confidently. You do not need to live in Connecticut to participate, as there will be no required in-person visits during the study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
14mo left

Started Jul 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress42%
Jul 2025Jul 2027

First Submitted

Initial submission to the registry

May 3, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 13, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

July 10, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

November 6, 2025

Status Verified

November 1, 2025

Enrollment Period

2 years

First QC Date

May 3, 2025

Last Update Submit

November 4, 2025

Conditions

Keywords

exercisephysical activitymobile phonehealth coachingfitness watch

Outcome Measures

Primary Outcomes (1)

  • Weekly exercise duration

    Minutes/week. Measured by blinded hip watch and periodic interviews. 0 minutes/week is the lowest value, 150 minutes/week meets clinically recommended amounts.

    20 weeks

Secondary Outcomes (13)

  • Weekly exercise volume

    20 weeks

  • Weekly exercise days

    20 weeks

  • Glucose

    20 weeks

  • Body mass index

    20 weeks

  • Waist circumference

    20 weeks

  • +8 more secondary outcomes

Study Arms (2)

Self-Monitoring

ACTIVE COMPARATOR

Wear a fitness watch and keep daily health diary

Behavioral: Self-monitoring

Exercise program

EXPERIMENTAL

Participants will receive a free Garmin smartwatch and a free program membership providing exercise coaching + personalized feedback about the relationship among their insulin, carbohydrates, exercise, sleep, and blood sugar.

Behavioral: Exercise program

Interventions

Participants will receive a free Garmin smartwatch and a free program membership providing exercise coaching + personalized feedback about the relationship among their insulin, carbohydrates, exercise, sleep, and blood sugar.

Exercise program
Self-monitoringBEHAVIORAL

Wear a fitness watch and keep daily health diary

Self-Monitoring

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old inclusive
  • Diagnosis with type 1 diabetes (T1D) or other insulin deficiency diabetes (latent autoimmune disease of adulthood, diabetes secondary to pancreatitis)
  • Less than 1.0 exercise sessions per week
  • Smartphone ownership
  • English literacy
  • Under regular care by a healthcare provider (1+ appointments per year)
  • Home Broadband wireless Internet or cell phone network
  • Using continuous glucose monitor (CGM) and sharing data with medical record for at least 6 weeks
  • Using insulin pump or pen and sharing data with medical record for at least 6 weeks

You may not qualify if:

  • Diabetic ketoacidosis not clearly related to pump site failure in past 6 months
  • \>1 episode of severe hypoglycemia (altered mental and/or physical status requiring assistance from another person for recovery) in past 6 months
  • A1c ≥10.0%
  • Resting blood pressure \>160mmHg systolic or \>100 mmHg diastolic.
  • Myocardial infarction or angina in past 12 months
  • Uncontrolled arrhythmia (e.g., atrial fibrillation with rapid ventricular response, new onset atrial fibrillation, ventricular tachycardia, escape rhythms)
  • Congestive heart failure (stage 3 or 4)
  • Exercise-induced asthma (not controlled on inhalers)
  • Chronic obstructive pulmonary disease (requiring home oxygen)
  • Renal failure
  • Pregnancy
  • Cognitive impairment
  • Severe retinopathy or neuropathy.
  • Other chronic disease or physical disability that would influence exercise intervention (e.g., recent spinal surgery)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale School of Medicine

New Haven, Connecticut, 06510, United States

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 1PancreatitisMotor Activity

Interventions

Resistance TrainingBlood Glucose Self-Monitoring

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesPancreatic DiseasesDigestive System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaBlood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, EndocrineMonitoring, PhysiologicSelf-TestingSelf CareInvestigative Techniques

Study Officials

  • Garrett Ash, PhD, CSCS

    Yale University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yashvi Verma, BS

CONTACT

Garrett Ash, PhD, CSCS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Medicine, Biomedical Informatics, and Data Science

Study Record Dates

First Submitted

May 3, 2025

First Posted

May 13, 2025

Study Start

July 10, 2025

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

November 6, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

Locations